Clinical Trial Update: Study of EQ101 in Adult Subjects With Moderate to Severe Alopecia Areata [Phase 2]

View source ↗

Summary

A Phase 2 study of EQ101 in adults with moderate-to-severe alopecia areata has completed and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alopecia Areata
• Alopecia Totalis
• Alopecia Universalis

Drugs mentioned

• EQ101

Snippet

Sponsor: Equillium | Conditions: Alopecia Areata, Alopecia | Phase 2 | Status: COMPLETED | Results posted: 2025-04-10